From bench to regulatory submission - writing informed by having done both.

I am a PhD-trained translational oncology scientist and medical writer with 15+ years of experience spanning research and clinical development, bringing hands-on expertise to every project.

My scientific career began in translational oncology and advanced through postdoctoral research on cancer stem cells, intestinal regeneration, and rare pediatric cancers. I investigated disease mechanisms, chemoresistance, metastasis, and therapeutic response, resulting in seven peer-reviewed publications in leading journals, a review article, a book chapter, and multiple conference presentations. Notably, I presented a first-author poster at AACR 2025 (selected as late-breaking) and served as leading author on a second AACR poster in 2026.

I transitioned to industry as a Senior Scientist in Translational Research and Clinical Development, leading programs in ctDNA-based biomarkers, GI oncology, and treatment-related peripheral neuropathy - contributing to clinical trial design, regulatory submissions, publications, and patents. I also supported strategic decision-making through competitive landscape analysis and data generation for clinical development and commercial positioning of the company's primary asset, as well as licensing discussions for non-oncology indications.

This diverse background enables me to understand how science is generated, evaluated, and applied in research, clinical, regulatory, and commercial settings - not just write about it.

Extended Network

Medical writing for biotech, biopharma and healthcare, backed by a network of physicians and scientists

Aureole Medical Communications is a Vancouver-based medical writing practice founded by a PhD translational oncology scientist and supported by a network of physicians and scientists. We translate complex scientific, clinical, and biomedical evidence into clear, compelling, and purposeful medical communications.

• Dr. Oksana Korolova, MD, PhD, ACRP-CPI, ACRP-PM, SCORA-CCRP
  Neurology, Oncology, Respiratory Diseases, Rare Diseases | Clinical Trial Management & Regulatory Compliance, Medical Affairs

• Dr. Deepshikha Dhiman, MBBS, MD
  Hematology, Precision Medicine, Cardiology, Rheumatology, Diabetes & Endocrinology | Clinical Input for CME, HCP Content & Patient Education

• Dr. Vijay S. Akhade, PhD
  Blood Diseases, Immunology, Molecular Biology, Targeted Therapies | Scientific & Publication Support

What this means for Clients

• Your evidence and data are interpreted, not just summarized

• Every claim is based on primary data and rigorous research, not secondary interpretation

• Narratives are crafted and tailored to your specific communication objectives and targeted audience

• Content is written for research, clinical, regulatory, medical affairs, and commercial audiences

• Data is connected to its broader clinical and development context to ensure content withstands expert scrutiny

• When a project calls for additional specialist input, I can draw on a trusted network of MD/PhD collaborators

Transforming complex data and science into clinical reality

If your next publication, submission, or presentation needs to withstand expert scrutiny, let's talk